meissa-vaccines

Meissa Vaccines Raises $30M to Advance RSV Vaccine into Clinical Trials

Meissa Vaccines Raises $30M to Advance RSV Vaccine into Clinical Trials

The funding will expand the team, enable clinical trials for Meissa’s investigational vaccine, and support a viral vaccine pipeline.

Meissa Vaccines Closes $3.4 Million Round to Advance RSV Vaccine to Clinic

Meissa Vaccines Closes $3.4 Million Round to Advance RSV Vaccine to Clinic

The Meissa team has developed a live attenuated vaccine with global utility.

JLABS resident Meissa Vaccines nabs new seed capital to advance RSV vaccine

JLABS resident Meissa Vaccines nabs new seed capital to advance RSV vaccine

Meissa was incorporated through QB3 Startup in a Box.